GP
GlaxoSmithKline PLC ADR
🇺🇸XNYS.GSKUnited StatesHealthcare
$50.25USDup +0.25 (+0.5%)OpenDelayed6:13 PM
Price$50.25+0.25 (+0.5%)
Profile
- Healthcare
- Drug Manufacturers - General
- United States
Identity
- Exchange
- New York Stock Exchange . XNYS
- Type
- Stock
- ISIN
- US37733W2044
- CUSIP
- 37733W105
Company
- Employees
- 66,841
- Headquarters
- London, United States
- Website
- https://www.gsk.com
- CEO
- Mr. Luke Victor Miels
Market
- Shares outstanding
- 2B
- Market cap
- $100.64B
Key dates
- Next earnings
- Nov 4, 2026
Highlights
- Market cap
- $100.26B
- EPS LTM
- $2.37
- P/E LTM
- 16.42
- Div yield
- 3.67%
Fundamentals (LTM)
- Revenue
- $33.2B+4.97%up year on year
- Net income
- $4.82B+40.84%up year on year
- Gross margin
- 72.73%+1.91%up year on year
- Free cash flow
- $6.98B+49.59%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.